Acarbose Treatment and the Risk of Cardiovascular Disease in Type 2 Diabetic Patients: A Nationwide Seven-Year Follow-Up Study
Objective. To investigate the potential benefits of acarbose treatment on cardiovascular disease (CVD) in patients with type 2 diabetes by using nationwide insurance claim dataset. Research Design and Methods. Among 644,792 newly diagnosed type 2 diabetic patients without preexisting CVD in a nation...
Saved in:
| Main Authors: | Jui-Ming Chen, Cheng-Wei Chang, Ying-Chieh Lin, Jorng-Tzong Horng, Wayne H.-H. Sheu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2014/812628 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular insights of acarbose metabolization catalyzed by acarbose-preferred glucosidase
by: Jiayong Huang, et al.
Published: (2025-08-01) -
Seven-Year Follow-Up of Peutz-Jeghers Syndrome
by: Hamid Reza Mozaffari, et al.
Published: (2016-01-01) -
NMR Data Analysis of Acarbose
by: LI Yujiang, et al.
Published: (2025-06-01) -
Metabolic syndrome treatment: focusing on acarbose
by: I. E. Chazova, et al.
Published: (2008-04-01) -
Postprandial hyperglycemia and cardiovascular events. Acarbose therapy in patients with coronary heart disease and impaired carbohydrate metabolism
by: N. A. Logunova, et al.
Published: (2008-10-01)